Lu YS, Bin Mohd Mahidin EI, Azim H, Eralp Y, et al. Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2- advanced breast cancer. J Clin Oncol 2024 May 21:JCO2400144. doi: 10.1200/JCO.24.00144.
PMID: 38771995